Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Chondrosarcoma × nilotinib × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 28 Leukemia 13 Gastrointestinal Stromal Tumors 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Leukemia, Myeloid, Chronic-Phase 6 Philadelphia Chromosome 3 Neoplasms 3 Leukemia, Myeloid 3 Hematologic Diseases 3 Bone Marrow Diseases 3 Myeloproliferative Disorders 2 Melanoma 2 Bronchiolitis Obliterans Syndrome 2 Blast Crisis 2 Synovitis, Pigmented Villonodular 1 Recurrence 1 Piebaldism 1 Neurofibromatoses 1 Neurofibroma, Plexiform 1 Neurofibroma 1 Neoplastic Processes 1 Neoplasms by Histologic Type 1 Neoplasm Metastasis 1 Mastocytosis, Systemic 1 Leukemia, Myeloid, Accelerated Phase 1 Hypereosinophilic Syndrome 1 Hematologic Neoplasms 1 Glioma 1 Giant Cell Tumor of Tendon Sheath 1 Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

HhAntag691 2 toripalimab 1 temsirolimus 1 pegfilgrastim 1 pazopanib 1 liposomal doxorubicin 1 enasidenib 1 angiotensin I (1-7) 1 Sunitinib 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Image-Guided 1 Radiotherapy, Conformal 1 Proton Therapy 1 Pharmacogenomic Testing 1 Microarray Analysis 1 Medicare Part B 1 Magnetic Resonance Spectroscopy 1 Immunologic Techniques 1 Gemcitabine 1 Filgrastim 1 Ferrosoferric Oxide 1 Fentanyl 1 Docetaxel 1 Dasatinib 1 Cyproheptadine 1 3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol 1 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡